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SUMMARY The Gianotti-Crosti syndrome is a relatively common children 
dermatosis characterized by a monomorphous erythematous papular rash 
limited to the face and extensor surface of the arms and legs. Although the 
pathogenesis is still unclear, infections are considered as the most impor-
tant factor. Human β-defensins are cationic antimicrobial peptides closely 
related to bacterial and viral infections of many epithelia. We herein report 
a case of Gianotti-Crosti syndrome in a 7-year-old Caucasian girl presented 
with prominent eruption consisting of dome-shaped lichenoid papules on 
her upper and lower extremities, with spontaneous resolution. Skin biopsy 
revealed a dense lichenoid lymphohistiocytic infiltrate and showed strong 
cytoplasmic immunopositivity for human β-defensin-4 in the stratum cor-
neum, stratum granulosum, and stratum spinosum. Considering that β-de-
fensins have been described to be induced by infections, we investigated 
the expression of human β-defensin-4 by immunohistochemistry in a case 
of Gianotti-Crosti syndrome, in order to demonstrate that it represents a cu-
taneous response to skin infections.
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INTRODUCTION
The Gianotti-Crosti syndrome (GCS), or papular ac-
rodermatitis of childhood, is a self-limited childhood 
exanthema associated with bacterial or viral infec-
tions or immunization. It is characterized by the acute 
onset of monomorphous, symmetric flat-topped 
papules or papulovesicles, which range in color from 
pink to red or brown and are usually located on the 
face, buttocks and extensor surfaces of the forearms 
and legs, with the trunk typically being spared. The 
lesions are occasionally pruritic and are self-limiting, 
lasting for up to 3 weeks. Mucous membranes are not 
affected. Systemic signs include hepatosplenomeg-
aly and axillary and inguinal lymphadenopathy (1). 
The pathogenesis of GCS is still unknown, although 
a number of hypotheses have been proposed. Con-
sidering that neither viral particles nor viral antigens 
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have been retrieved in the skin lesions of GCS (2), it 
has been postulated that the lesion development 
does not involve direct local interaction between viral 
antigens and immune-competent cells in the skin. 
Human β-defensins (hBD) are small cationic pep-
tides with a broad spectrum of antimicrobial activity. 
hBD-4 exhibited the same genomic organization as 
other β-defensins, with two exons flanking an in-
tron of 4495 bp (3). Because β-defensins have been 
described to be induced by infections, we investigat-
ed the expression of hBD-4 by immunohistochemis-
try in a case of GCS, in order to deepen the insight 
into its pathogenesis.
CASE REPORT
A previously healthy 7-year-old Caucasian girl 
presented with a two-week history of rash associated 
Caltabiano et al. Acta Dermatovenerol Croat
Human beta-defensin in Gianotti-Crosti syndrome 2013;21(1):43-47
Figure 1. (A) Prominent eruption consisting of non pruritic pink 1-2 mm flat-topped and dome-shaped lichenoid papules on up-
per extremities of the patient; (B) at 3-week follow-up, partial spontaneous healing with flattening of the papules was observed.
Figure 2. (A) Histologic examination showed compact orthokeratosis, focal parakeratosis, hypergranulosis, psoriasiform epi-
dermal hyperplasia, and a dense lichenoid lymphohistiocytic infiltrate (H&E, X100x); (B) at higher magnification, the lichen-
oid pattern was evident (H&E, X200). 
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with low-grade fever and lymphadenopathy. Family 
history was unremarkable. The patient was taking no 
medications, and her past medical history revealed 
a respiratory syncytial virus infection before the on-
set of the rash. On physical examination, the patient 
was a normally developed playful child. A prominent 
eruption consisting of non pruritic pink 1-2 mm flat-
topped and dome-shaped lichenoid papules was 
present on her upper and lower extremities (Fig. 1A). 
No lesions of the mouth and nails were observed. 
Enlarged, soft, freely movable lymph nodes were ap-
preciated at the axillary and inguinal region. Throat 
culture, mononucleosis test, serologic tests for hepa-
titis viruses and routine blood tests were within the 
normal limits. Therefore, we decided to perform an 
incisional biopsy on the dorsum of the left hand. No 
therapy was administered and partial spontaneous 
healing with flattening of the papules (Fig. 1B) en-
sued in approximately 3 weeks. 
MATERIALS AND METHODS
Surgical specimen was fixed in 10% buffered for-
malin, routinely processed and embedded in paraffin. 
The 4-μm thick sections were stained with hematoxy-
lin and eosin. Additional sections were cut for im-
munohistochemical procedures. The immunohisto-
chemical assay was performed on 4-μm sections cut 
from the blocks and float-mounted on Super Frost/
Plus slides. Slides were deparaffinized and rehydrat-
ed through xylenes and graded ethanol solutions to 
water. Antigen retrieval was performed by the heat 
method in which the specimens were placed in a citric 
acid solution (Target Retrieval Solution, pH 6.1; Dako 
Cytomation, Glostrup, Denmark), for 30 min at 94 °C 
using a vegetable steamer and then brought to room 
temperature for 20 min. All slides were quenched for 
5 min in 0.03% hydrogen peroxide (EnVision+ Sys-
tem-HRP (DAB), Dako Cytomation) to block for en-
dogenous peroxidase. The primary antibody, mouse 
anti-human β-defensin-4 antibody (Santa Cruz Bio-
technology), diluted 1:50, was applied for 60 min in 
moist chamber. After washing in Tris-buffered saline 
(TBS) at pH 7.6, secondary antibody (Goat IgG anti-
body, Donkey polyclonal to Goat IgG-H&L (HRP), Ab-
cam, Cambridge, UK) was applied for 30 min in moist 
chamber. The sections were again washed in TBS. 
Staining was completed by 10-min incubation with 
3,3á-diaminobenzidine (DAB) substrate-chromogen 
(Dako Cytomation). Slides were then counterstained 
in hematoxylin and dehydrated through graded eth-
anol solutions. Slides were mounted using the Fara-
mount aqueous medium (Dako).
RESULTS
Histologic examination of the biopsy specimen 
obtained from the dorsum of the left hand revealed 
compact orthokeratosis, focal parakeratosis, hyper-
granulosis, psoriasiform epidermal hyperplasia, and 
a dense lichenoid lymphohistiocytic infiltrate (Fig. 
2A-B). The clinical and histopathologic features were 
consistent with the diagnosis of lichen planus. Never-
theless, the absence of pruritus, the absence of mouth 
and nail lesions, and the coexistence of systemic 
manifestations led us to consider the diagnosis of 
papular acrodermatitis of childhood (Gianotti-Crosti 
Figure 3. Intense cytoplasmic immunoreactivity for hu-
man β-defensin-4 (hBD-4) in the cells of the upper spinous, 
granular and keratinized layers (IHC, X200).
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syndrome, GCS) presenting as lichenoid dermatitis. 
On immunohistochemistry, immunoreactivity for 
hBD-4 in the stratum corneum, stratum granulosum, 
and stratum spinosum was observed (Fig. 3).
DISCUSSION
Gianotti-Crosti syndrome, which was first de-
scribed in 1955 (4), is a rare disease representing a 
cutaneous response to a number of viral infections. It 
is a self-limiting dermatosis occurring more common 
in children, without racial predilection. It was first re-
lated to hepatitis B virus infection; however, it may be 
associated with several other viral infections includ-
ing cytomegalovirus (5), Epstein-Barr virus (2), respi-
ratory syncytial virus, parainfluenza (6), enterovirus 
(7), and coxsackie virus (8). Primary lesions are usu-
ally papules or papulovesicles sometimes coalescing 
into plaques over the elbows and knees. The eruption 
is usually acrally distributed with involvement of the 
thighs, buttocks, extensor aspects of the arms, legs 
and the face. Although biopsies of skin lesions show 
nonspecific histologic features, both vesicular and 
non-vesicular patterns can be seen. Unlike our case, 
the upper dermis usually shows interstitial dermati-
tis with mild to moderate perivascular lymphohistio-
cytic infiltrate and occasional scattered eosinophils 
in the superficial and mid-dermis (9). As previously 
reported in the literature (10), the histopathology of 
the lesions in our patient revealed a diffuse lichenoid 
infiltrate. The histopathologic differential diagnosis of 
a lichenoid infiltrate in childhood includes different 
diseases. In lichen planus, the papules are distributed 
over the flexural areas and, unlike GCS, are intensely 
pruritic. Mouth and nails are usually affected. Histo-
pathologically, in lichen planus, globular eosinophilic 
deposits (Civatte bodies) and melanophages are evi-
dent at the dermoepidermal junction. Rare cases of 
drug induced lichenoid eruption in children exhibit 
mouth lesions and a less band-like infiltrate with eo-
sinophils (11). 
Antimicrobial peptides represent very important 
mediators of the innate immune response widely 
distributed from invertebrates to mammals. They are 
mainly expressed in the skin and mucosal epithelia, 
where they prevent colonization by pathogens (12). 
Most of them are small, cationic and hydrophobic 
molecules that insert into biological membranes and 
lyse a broad spectrum of pathogens such as bacteria, 
viruses, fungi and protozoa. One characteristic abnor-
mality of lesional skin in psoriasis is the excessive pro-
duction of beta defensins (13). Patients with atopic 
dermatitis are predisposed to infection with Staphylo-
coccus aureus, which worsens their skin disease; it has 
been postulated that the lack of antimicrobial pep-
tides, due to aberrant allergic inflammation in the skin 
with atopic dermatitis, could mediate this enhanced 
bacterial susceptibility (14). hBD-4 is an endogenous 
salt-dependent antimicrobial peptide that inhibits 
the growth of gram-positive bacteria, gram-negative 
bacteria, yeasts and viruses. hBD-4, constitutively ex-
pressed in the testis, the gastric antrum, the uterus, 
the thyroid, the lung and the kidney, is not normally 
expressed in skin samples (3). Nevertheless, the in-
ducible expression of hBD-4 by keratinocytes has 
also been confirmed (15). As reported in the literature 
(16), hBD-4 stimulates gene expression and produc-
tion of various proinflammatory cytokines and che-
mokines by human primary keratinocytes probably 
related to immune complex-mediated mechanisms 
of GCS. Also, unlike hBD-1, gene expression of hBD-4 
was strongly upregulated by skin infections (17). Our 
case of GCS showed strong cytoplasmic positivity for 
hBD-4 in the upper spinous, granular, and keratinized 
layers. For this reason, it demonstrates that GCS in-
duces transcription of the gene coding for hBD-4 in 
the skin. Considering that defensins play an impor-
tant role in host defense against the invading patho-
gens, our observation indicates that hBD-4 may have 
a function in response to viral infection in GCS that 
is related to pathogen elimination. This observation 
might indicate that viral antigenemia rather than the 
formation of immune complexes has a crucial role in 
the pathogenesis of the syndrome. With regard to the 
antiviral activity of defensins, their mechanisms have 
not yet been thoroughly understood. Viral infection 
can induce the expression of defensins, defensins act 
as chemotactic agents, and defensins can directly af-
fect the virion. Regarding this direct effect, one aspect 
involves direct interaction with viral envelopes, and 
the other involves indirect antiviral activity through 
interactions with the potential target cells (18).
CONCLUSION
Our case represents one of the different kinds of 
histopathologic presentation of GCS and it should be 
considered in the diagnosis of lichenoid dermatitis 
in children in order to avoid unnecessary treatment. 
Although a type of delayed hypersensitivity reaction 
is speculated as a cause, our observation of hBD-4 ex-
pression in GCS may suggest direct local interaction 
between viral antigens and immune-competent cells 
in the skin.
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